Seer Wins Proteomics Solution of the Year by BioTech Breakthrough and Named #5 on Deloitte Technology Fast 500GlobeNewsWire • 11/08/23
Seer Collaborates to Make Scalable, Unbiased Proteomics Accessible to More Researchers via new Seer Technology Access CenterGlobeNewsWire • 06/07/23
Seer Launches the Proteograph XT Assay Kit: Allowing Labs to Easily Expand Their View of the Proteome and Scale Their StudiesGlobeNewsWire • 06/01/23
Seer's Proteograph™ Product Suite identifies undiscovered links between protein variants and lung cancer progressionGlobeNewsWire • 03/29/23
Seer Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Full Year 2023 OutlookGlobeNewsWire • 03/02/23
Down -26.63% in 4 Weeks, Here's Why You Should You Buy the Dip in Seer, Inc. (SEER)Zacks Investment Research • 02/27/23
Seer, Inc. (SEER) Expected to Beat Earnings Estimates: Can the Stock Move Higher?Zacks Investment Research • 02/23/23